Home » Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model – British Journal of Cancer

Editorial Expression of Concern: Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model – British Journal of Cancer

by Kususda, Y., Miyake, H., Gleave, M. E. & Fujisawa, M. | Dec 3, 2024 | Articles | 0 Comments